600976.SS · 健民集团
China A-shares · RS rating 35 · As of 2026-10-14
| Price | 26.99 CNY |
|---|---|
| 1-day change | -0.3% |
| RS rating (overall / 1M / 3M / 12M) | 35 / 62 / 49 / 20 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 20 / 13 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -15.5% |
| Distance from 52-week high | +33.9% |
| Market cap (USD) | $618.9M |